In 2025, industry figures show the Oman market stood at USD 378.5 million.
Our industry-aligned projections anticipate the Oman Infusion Services Market will achieve USD 1.32 billion by 2033, with a forecasted CAGR of 16.9% during the forecast period.
Gradual tertiary care expansion is strengthening oncology infusion availability, particularly within Muscat-based referral hospitals.
Oman Ministry of Health non-communicable disease indicators show sustained cancer incidence levels, underpinning steady systemic therapy demand.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]